Exclusive: #Drugmakers raise #US #prices on 350 medicines despite pressure from #Trump
Drugmakers plan to raise US prices on at least 350 branded #medications including #vaccines against #COVID, #RSV & #shingles & blockbuster #cancer treatment Ibrance, even as the Trump admin pressures them for cuts, acc/to data provided exclusively by #healthcare research firm 3 Axis Advisors.
#law #affordability #CostOfLiving #CostOfDying #HealthyIfYoureWealthy #medicine #BigPharma
https://www.reuters.com/business/healthcare-pharmaceuticals/drugmakers-raise-us-prices-350-medicines-despite-pressure-trump-2025-12-31/?utm_source=braze&utm_medium=notifications&utm_campaign=2025_engagement
How #PrivateEquity Oversees the #Ethics of #DrugResearch
Many #DrugTrials are vetted by companies with ties to the #drugmakers, raising concerns about #ConflictsOfInterest & #patient #safety.
#law #PublicHealth
https://www.nytimes.com/2025/10/04/health/drug-trials-ethics-ozempic.html?smid=nytcore-ios-share&referringSource=articleShare
This would be a surprisingly good thing if it happened. Somehow I doubt #BigPharma & #Republicans will allow it.
#Drugmakers have been warned that the #Trump Administration is considering linking US #medicine #prices to lower amounts paid by other developed countries, acc/to 2 company sources who called the option the pharmaceutical industry's top concern.
#BioTech industry responsible for more than 115,000 #Massachusetts jobs is struggling amidst a slump. The #Boston area is a bio research hub with 1,000 #drugmakers, but part of problem for the NE Democrat political and #science edu stronghold is higher costs of operations than elsewhere.
For example, In burgeoning #RaleighDurham NC Triangle drugmakers face far lower taxes and can pay lower wages.
https://www.statnews.com/2025/03/13/biotech-boston-area-slump/
Reuters "#Drugmakers to raise US prices on over 250 medicines starting Jan. 1...A Reuters analysis of prices for new drugs found that pharmaceutical companies launched new U.S. drugs in 2023 at prices 35% higher than in 2022."
https://finance.yahoo.com/news/drugmakers-raise-us-prices-over-120529214.html
#NewYear
New rules require drugmakers to be clearer about explaining the risks and side effects of prescription drugs. The new guidelines from the the Food and Drug Administration are designed to do away with pharmaceutical industry practices that downplay or distract viewers' attention from risk information. FDA officials spent more than 15 years crafting the rules, which apply to both TV and radio ads. But while regulators were drafting them, a new trend has emerged: pharmaceutical influencers pushing drugs online with little government oversight. A new congressional proposal would compel FDA to police those social media promotions.